Literature DB >> 7551884

Impact of tumour grade, stage, number and size, and smoking and sex, on survival in patients with transitional cell carcinoma of the bladder.

M P Raitanen1, P Nieminen, T L Tammela.   

Abstract

OBJECTIVE: To evaluate the impact of the grade, stage number and size of the tumour and of smoking and sex of patient on survival, and the relationship between smoking and tumour grade, stage, number and size, and sex of patient in patients with transitional cell carcinoma (TCC) of the urinary bladder. PATIENTS AND METHODS: The study comprised 252 consecutive patients with histologically verified TCC of the bladder reporting to Oulu University Central Hospital between 1978 and 1986. The average duration of follow-up was 6.7 years. The association between smoking and other covariates was analysed by cross-tabulation and standard chi-squared analyses. The Kaplan-Meier method was used to obtain estimated survival curves and significant differences determined using log rank statistics.
RESULTS: Smoking had no impact on tumour grade, stage, size and number or aggressiveness of metastases. Prognosis was noticeably better if the patient did not smoke, as 27% of the non-smokers and 40% of the smokers had died during the first 10 years after diagnosis. Survival was also better in patients with low grade (I, II), non-invasive (Ta/T1) and small (< or = 3 cm) tumours.
CONCLUSION: In addition to the well-known prognostic factors (histological grade and stage of the tumour), smoking is a risk factor for bladder cancer and also has an impact on prognosis, leading to higher mortality from the disease in the longer term.

Entities:  

Mesh:

Year:  1995        PMID: 7551884     DOI: 10.1111/j.1464-410x.1995.tb07748.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  13 in total

Review 1.  Chemoprevention of bladder cancer.

Authors:  Dragan J Golijanin; David Kakiashvili; Ralph R Madeb; Edward M Messing; Seth P Lerner
Journal:  World J Urol       Date:  2006-11       Impact factor: 4.226

Review 2.  Current concepts in the role of intravesical instillations in the therapy and prophylaxis of superficial transitional-cell cancer of the bladder. The Finnbladder Research Group.

Authors:  O Alfthan; K Jauhiainen; E Kaasinen; T Liukkonen
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

3.  [Secondary prevention in patients with superficial urothelial carcinoma].

Authors:  T J Schnöller; F Zengerling; C Hirning; F Jentzmik
Journal:  Urologe A       Date:  2015-07       Impact factor: 0.639

4.  Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.

Authors:  Andreas Eisenhardt; Winfried Siffert; Dieter Rosskopf; Michael Musch; Max Mosters; Ulla Roggenbuck; Karl-Heinz Jöckel; Herbert Rübben; Gerd Lümmen
Journal:  World J Urol       Date:  2005-11-08       Impact factor: 4.226

5.  Cigarette smoking and subtypes of bladder cancer.

Authors:  Xuejuan Jiang; J Esteban Castelao; Jian-Min Yuan; Mariana C Stern; David V Conti; Victoria K Cortessis; Malcolm C Pike; Manuela Gago-Dominguez
Journal:  Int J Cancer       Date:  2011-05-09       Impact factor: 7.396

6.  Prediction of prognosis after radical cystectomy for pathologic node-negative bladder cancer.

Authors:  Eun Park; Hong Koo Ha; Moon Kee Chung
Journal:  Int Urol Nephrol       Date:  2011-05-28       Impact factor: 2.370

7.  [Prognostic value of preoperative serum albumin in patients with non-muscle-invasive bladder cancer undergoing transurethral resection of bladder tumor].

Authors:  Yue Zhang; Fei Li; Fan Yang; Wen-Li Zeng; Hao Lin; Qi-Liang Zhai; Ming-Qiang Su; Zi-Hao Chen; Wan-Long Tan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-02-20

8.  Patient awareness of smoking as a risk factor for bladder cancer.

Authors:  Ioannis Anastasiou; Vasilios Mygdalis; Anastasios Mihalakis; Ioannis Adamakis; Constantinos Constantinides; Dionisios Mitropoulos
Journal:  Int Urol Nephrol       Date:  2009-07-10       Impact factor: 2.370

9.  Lifestyle and Non-muscle Invasive Bladder Cancer Recurrence, Progression, and Mortality: Available Research and Future Directions.

Authors:  Kyle B Zuniga; Rebecca E Graff; David B Feiger; Maxwell V Meng; Sima P Porten; Stacey A Kenfield
Journal:  Bladder Cancer       Date:  2020-03-28

10.  The prognostic value of preoperative serum albumin in patients with bladder urothelial carcinoma undergoing transurethral resection of bladder tumor: A prospective cohort study.

Authors:  Chen Shen; Kechong Zhou; Wei Wang; Yue Zhang; Xiaoqiang Liu
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.